FDA
Amneal
Nov 27
— 0.00
Amneal Pharmaceuticals of New York LLC announced the FDA approval of its generic oxycodone and acetaminophen tablet, a milestone expected to bolster the company's presence in the c…
FDA
Allergan,
Oct 30
— 0.00
# FDA Approves Allergan's COMBIGAN for Glaucoma Treatment
Allergan, Inc. received FDA approval for COMBIGAN (brimonidine tartrate and timolol maleate), an ophthalmic combination t…
FDA
Glenmark
Oct 9
— 0.00
# FDA Approves Glenmark Pharmaceuticals' Generic Oxcarbazepine
Glenmark Pharmaceuticals Inc., USA received FDA approval for its generic oxcarbazepine oral formulation, potentially…
FDA
Teva
Oct 5
— 0.00
# FDA Approves Teva Pharmaceuticals' Generic Risedronate Sodium
Teva Pharmaceuticals USA, Inc. received FDA approval for its generic formulation of risedronate sodium, a widely-pr…
FDA
AUROBINDO
Jun 29
— 0.00
# FDA Approves Aurobindo Pharma USA Generic Drug Application
Aurobindo Pharma USA received FDA approval for ANDA 077873 on June 29, 2007, expanding the company's generic drug port…
FDA
PHARM
Jun 25
— 0.00
# FDA Approves Generic Drug Application for Pharm Assoc
Pharm Assoc has received FDA approval for ANDA078127, expanding its generic drug portfolio and positioning the company to c…
FDA
Accord
Apr 26
— 0.00
# FDA Approves Accord Healthcare's Generic Fluorouracil Injection
Accord Healthcare, Inc. has received FDA approval for its generic intravenous fluorouracil formulation (ANDA04079…
FDA
Takeda
Feb 23
— 0.00
Takeda Pharmaceuticals America, Inc.'s VYVANSE (lisdexamfetamine dimesylate) received FDA approval for oral administration. The clearance allows the brand to retain its proprietary…
FDA
Haleon
Feb 7
— 0.00
# FDA Approves Haleon's Orlistat (Alli) for Over-the-Counter Weight Management
Haleon US Holdings LLC received FDA approval for Alli (orlistat), marking the first nonprescription …
FDA
HERITAGE
Feb 6
— 0.00
# FDA Approves Heritage Pharma Avet's ANDA Application
Heritage Pharma Avet has received FDA approval for its Abbreviated New Drug Application (ANDA077663), expanding the company'…
FDA
Strides
Jan 31
— 0.00
Strides Pharma Science Limited announced the FDA approval of its oral Oxycodone Hydrochloride generic, a move anticipated to intensify competitive pricing and drive generic market …
FDA
Dr.
Dec 26
— 0.00
# FDA Approves Dr. Reddy's Laboratories' Generic Ondansetron
Dr. Reddy's Laboratories Limited received FDA approval for its generic ondansetron hydrochloride oral formulation, exp…
FDA
West-Ward
Dec 26
— 0.00
West-Ward Pharmaceuticals Corp. secured FDA approval for its intramuscular formulation of ondansetron hydrochloride, a move that positions the company to capitalize on the competit…
FDA
STRIDES
Nov 6
— 0.00
Strides Pharma announced the FDA approval of Metolazone Tablets, expanding its portfolio of cardiac and kidney care generic therapies and reinforcing its competitive position in th…
FDA
Amneal
Oct 24
— 0.00
# FDA Approves Amneal Pharmaceuticals' Generic Colestipol Hydrochloride
Amneal Pharmaceuticals of New York LLC received FDA approval for its generic colestipol hydrochloride oral …
FDA
LANNETT
Oct 13
— 0.00
# FDA Approves ANDA for Lannett Co Inc
Lannett Co Inc received FDA approval for ANDA077960 on October 13, 2006, expanding its generic drug portfolio and positioning the company to…
FDA
Amneal
Aug 25
— 0.00
Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminophen, solidifying its presence …
FDA
GRAVITI
Jul 26
— 0.00
Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate revenue through competitive prici…
FDA
SOLA
Dec 29
— 0.00
# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline
The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabergoline oral tablets, potentia…
FDA
Torrent
Dec 7
— 0.00
# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine
Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine oral formulation, expanding t…